Skip to main content
. 2019 Jan 30;33(4):1023–1029. doi: 10.1038/s41375-019-0391-2

Fig. 2.

Fig. 2

Kaplan–Meier curves of OS and PFS of all, low-risk, medium-risk, and high-risk patients treated with ASCT, MDex, or LDex (a) PFS in all patients, (b) OS in all patients, (c) PFS in low-risk patients, (d) PFS in medium-high risk patients, (e) OS in low-risk patients, and (f) OS in medium-high risk patients